Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models—I. 6-[ 3H]-5-fluorouracil

The differential tissue distribution and urinary excretion of small intravenous doses (4 μg kg −1) of 6-[ 3H]-5-fluorouracil have been studied in two strains of mice bearing transplantable tumors. The subcutaneous Lewis Lung carcinoma and the solid Ehrlich Ascites carcinoma both retained less than 1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of nuclear medicine & biology 1979, Vol.6 (2), p.97-101
Hauptverfasser: Abrams, D.N., Knaus, E.E., Wiebe, L.I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 101
container_issue 2
container_start_page 97
container_title International journal of nuclear medicine & biology
container_volume 6
creator Abrams, D.N.
Knaus, E.E.
Wiebe, L.I.
description The differential tissue distribution and urinary excretion of small intravenous doses (4 μg kg −1) of 6-[ 3H]-5-fluorouracil have been studied in two strains of mice bearing transplantable tumors. The subcutaneous Lewis Lung carcinoma and the solid Ehrlich Ascites carcinoma both retained less than 1.5% of the dose, and for all tissues assayed the tumor: blood ratios for radioactivity were 11:1 or less. Approximately 75% of the injected dose was excreted during the first 12 h. Urinary excretion was resolved using a two-compartmental model. The half-life of the fast component was just over 1 h while that for the slow component was in excess of 10 days.
doi_str_mv 10.1016/0047-0740(79)90003-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_74699692</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0047074079900032</els_id><sourcerecordid>74699692</sourcerecordid><originalsourceid>FETCH-LOGICAL-c271t-ccd97a6d9ae8f7a3acf99593b5ff96fa45e3e6d3fbf5135ea7705cf6869080a43</originalsourceid><addsrcrecordid>eNp9kLlKBTEUhlO4L29gkUq0GM1syaQRRNxAsNFKJJxJTiCamVyTG8HOh_AJfRLnekWwsTrwb3A-QvZKdlSykh8z1oiCiYYdCHkoGWN1Ua2QzV95g2yl9MRY1TUtXydrjeiEqDZJvstDiDTP5vCMNFgawbjgoUePhs7eohuccSPSHhImCuMfcczaY0jOTJYbJ9cN4OkQDPr0-f5xfUR58UDrq8eiLazPIYYcQTu_Q1Yt-IS7P3eb3F-c351dFTe3l9dnpzeFrkQ5L7Q2UgA3ErCzAmrQVspW1n1rreQWmhZr5Ka2vW3LukUQgrXa8o5L1jFo6m2yv9ydxfCSMc3V4JJG72HEkJMSDZeSy2oKNsugjiGliFbNpichvqmSqQVgtSCpFiSVkOobsFrU9n72cz-g-S0t6U72ydKecOCrw6iSdjhqNC6inisT3P_7Xy85jpA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>74699692</pqid></control><display><type>article</type><title>Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models—I. 6-[ 3H]-5-fluorouracil</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Abrams, D.N. ; Knaus, E.E. ; Wiebe, L.I.</creator><creatorcontrib>Abrams, D.N. ; Knaus, E.E. ; Wiebe, L.I.</creatorcontrib><description>The differential tissue distribution and urinary excretion of small intravenous doses (4 μg kg −1) of 6-[ 3H]-5-fluorouracil have been studied in two strains of mice bearing transplantable tumors. The subcutaneous Lewis Lung carcinoma and the solid Ehrlich Ascites carcinoma both retained less than 1.5% of the dose, and for all tissues assayed the tumor: blood ratios for radioactivity were 11:1 or less. Approximately 75% of the injected dose was excreted during the first 12 h. Urinary excretion was resolved using a two-compartmental model. The half-life of the fast component was just over 1 h while that for the slow component was in excess of 10 days.</description><identifier>ISSN: 0047-0740</identifier><identifier>DOI: 10.1016/0047-0740(79)90003-2</identifier><identifier>PMID: 478772</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Carcinoma, Ehrlich Tumor - metabolism ; Carcinoma, Ehrlich Tumor - urine ; Fluorouracil - metabolism ; Fluorouracil - urine ; Half-Life ; Lung Neoplasms - metabolism ; Lung Neoplasms - urine ; Male ; Mice ; Models, Biological ; Neoplasm Transplantation ; Neoplasms, Experimental - metabolism ; Neoplasms, Experimental - urine ; Pyrimidine Nucleosides - metabolism ; Pyrimidine Nucleosides - urine ; Time Factors ; Tritium</subject><ispartof>International journal of nuclear medicine &amp; biology, 1979, Vol.6 (2), p.97-101</ispartof><rights>1979</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c271t-ccd97a6d9ae8f7a3acf99593b5ff96fa45e3e6d3fbf5135ea7705cf6869080a43</citedby><cites>FETCH-LOGICAL-c271t-ccd97a6d9ae8f7a3acf99593b5ff96fa45e3e6d3fbf5135ea7705cf6869080a43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/478772$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abrams, D.N.</creatorcontrib><creatorcontrib>Knaus, E.E.</creatorcontrib><creatorcontrib>Wiebe, L.I.</creatorcontrib><title>Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models—I. 6-[ 3H]-5-fluorouracil</title><title>International journal of nuclear medicine &amp; biology</title><addtitle>Int J Nucl Med Biol</addtitle><description>The differential tissue distribution and urinary excretion of small intravenous doses (4 μg kg −1) of 6-[ 3H]-5-fluorouracil have been studied in two strains of mice bearing transplantable tumors. The subcutaneous Lewis Lung carcinoma and the solid Ehrlich Ascites carcinoma both retained less than 1.5% of the dose, and for all tissues assayed the tumor: blood ratios for radioactivity were 11:1 or less. Approximately 75% of the injected dose was excreted during the first 12 h. Urinary excretion was resolved using a two-compartmental model. The half-life of the fast component was just over 1 h while that for the slow component was in excess of 10 days.</description><subject>Animals</subject><subject>Carcinoma, Ehrlich Tumor - metabolism</subject><subject>Carcinoma, Ehrlich Tumor - urine</subject><subject>Fluorouracil - metabolism</subject><subject>Fluorouracil - urine</subject><subject>Half-Life</subject><subject>Lung Neoplasms - metabolism</subject><subject>Lung Neoplasms - urine</subject><subject>Male</subject><subject>Mice</subject><subject>Models, Biological</subject><subject>Neoplasm Transplantation</subject><subject>Neoplasms, Experimental - metabolism</subject><subject>Neoplasms, Experimental - urine</subject><subject>Pyrimidine Nucleosides - metabolism</subject><subject>Pyrimidine Nucleosides - urine</subject><subject>Time Factors</subject><subject>Tritium</subject><issn>0047-0740</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1979</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kLlKBTEUhlO4L29gkUq0GM1syaQRRNxAsNFKJJxJTiCamVyTG8HOh_AJfRLnekWwsTrwb3A-QvZKdlSykh8z1oiCiYYdCHkoGWN1Ua2QzV95g2yl9MRY1TUtXydrjeiEqDZJvstDiDTP5vCMNFgawbjgoUePhs7eohuccSPSHhImCuMfcczaY0jOTJYbJ9cN4OkQDPr0-f5xfUR58UDrq8eiLazPIYYcQTu_Q1Yt-IS7P3eb3F-c351dFTe3l9dnpzeFrkQ5L7Q2UgA3ErCzAmrQVspW1n1rreQWmhZr5Ka2vW3LukUQgrXa8o5L1jFo6m2yv9ydxfCSMc3V4JJG72HEkJMSDZeSy2oKNsugjiGliFbNpichvqmSqQVgtSCpFiSVkOobsFrU9n72cz-g-S0t6U72ydKecOCrw6iSdjhqNC6inisT3P_7Xy85jpA</recordid><startdate>1979</startdate><enddate>1979</enddate><creator>Abrams, D.N.</creator><creator>Knaus, E.E.</creator><creator>Wiebe, L.I.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1979</creationdate><title>Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models—I. 6-[ 3H]-5-fluorouracil</title><author>Abrams, D.N. ; Knaus, E.E. ; Wiebe, L.I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c271t-ccd97a6d9ae8f7a3acf99593b5ff96fa45e3e6d3fbf5135ea7705cf6869080a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1979</creationdate><topic>Animals</topic><topic>Carcinoma, Ehrlich Tumor - metabolism</topic><topic>Carcinoma, Ehrlich Tumor - urine</topic><topic>Fluorouracil - metabolism</topic><topic>Fluorouracil - urine</topic><topic>Half-Life</topic><topic>Lung Neoplasms - metabolism</topic><topic>Lung Neoplasms - urine</topic><topic>Male</topic><topic>Mice</topic><topic>Models, Biological</topic><topic>Neoplasm Transplantation</topic><topic>Neoplasms, Experimental - metabolism</topic><topic>Neoplasms, Experimental - urine</topic><topic>Pyrimidine Nucleosides - metabolism</topic><topic>Pyrimidine Nucleosides - urine</topic><topic>Time Factors</topic><topic>Tritium</topic><toplevel>online_resources</toplevel><creatorcontrib>Abrams, D.N.</creatorcontrib><creatorcontrib>Knaus, E.E.</creatorcontrib><creatorcontrib>Wiebe, L.I.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of nuclear medicine &amp; biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abrams, D.N.</au><au>Knaus, E.E.</au><au>Wiebe, L.I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models—I. 6-[ 3H]-5-fluorouracil</atitle><jtitle>International journal of nuclear medicine &amp; biology</jtitle><addtitle>Int J Nucl Med Biol</addtitle><date>1979</date><risdate>1979</risdate><volume>6</volume><issue>2</issue><spage>97</spage><epage>101</epage><pages>97-101</pages><issn>0047-0740</issn><abstract>The differential tissue distribution and urinary excretion of small intravenous doses (4 μg kg −1) of 6-[ 3H]-5-fluorouracil have been studied in two strains of mice bearing transplantable tumors. The subcutaneous Lewis Lung carcinoma and the solid Ehrlich Ascites carcinoma both retained less than 1.5% of the dose, and for all tissues assayed the tumor: blood ratios for radioactivity were 11:1 or less. Approximately 75% of the injected dose was excreted during the first 12 h. Urinary excretion was resolved using a two-compartmental model. The half-life of the fast component was just over 1 h while that for the slow component was in excess of 10 days.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>478772</pmid><doi>10.1016/0047-0740(79)90003-2</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0047-0740
ispartof International journal of nuclear medicine & biology, 1979, Vol.6 (2), p.97-101
issn 0047-0740
language eng
recordid cdi_proquest_miscellaneous_74699692
source MEDLINE; Alma/SFX Local Collection
subjects Animals
Carcinoma, Ehrlich Tumor - metabolism
Carcinoma, Ehrlich Tumor - urine
Fluorouracil - metabolism
Fluorouracil - urine
Half-Life
Lung Neoplasms - metabolism
Lung Neoplasms - urine
Male
Mice
Models, Biological
Neoplasm Transplantation
Neoplasms, Experimental - metabolism
Neoplasms, Experimental - urine
Pyrimidine Nucleosides - metabolism
Pyrimidine Nucleosides - urine
Time Factors
Tritium
title Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models—I. 6-[ 3H]-5-fluorouracil
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T15%3A36%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumor%20uptake%20of%20radiolabeled%20pyrimidine%20bases%20and%20pyrimidine%20nucleosides%20in%20animal%20models%E2%80%94I.%206-%5B%203H%5D-5-fluorouracil&rft.jtitle=International%20journal%20of%20nuclear%20medicine%20&%20biology&rft.au=Abrams,%20D.N.&rft.date=1979&rft.volume=6&rft.issue=2&rft.spage=97&rft.epage=101&rft.pages=97-101&rft.issn=0047-0740&rft_id=info:doi/10.1016/0047-0740(79)90003-2&rft_dat=%3Cproquest_cross%3E74699692%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=74699692&rft_id=info:pmid/478772&rft_els_id=0047074079900032&rfr_iscdi=true